Array BioPharma CEO Ron Squarer's 2018 pay rises 18% to $5.6M
Array BioPharma reports 2018 executive compensation
By ExecPay News
Published: September 14, 2018
Array BioPharma reported fiscal year 2018 executive compensation information on September 14, 2018.
In 2018, five executives at Array BioPharma received on average a compensation package of $3.5M, a 51% increase compared to previous year.
Average pay of disclosed executives at Array BioPharma
Ron Squarer, Chief Executive Officer, received $5.6M in total, which increased by 18% compared to 2017. 60% of Squarer's compensation, or $3.3M, was in option awards. Squarer also received $474K in non-equity incentive plan, $616K in salary, $1.1M in stock awards, as well as $52K in other compensation.
Curtis Oltmans, General Counsel, received a compensation package of $4M. 75% of the compensation package, or $3M, was in option awards.
Andrew R. Robbins, Chief Operating Officer, earned $3.2M in 2018, a 17% increase compared to previous year.
Victor Sandor, Chief Medical Officer, received $2.9M in 2018, which increases by 17% compared to 2017.
Jason Haddock, Chief Financial Officer, earned $1.8M in 2018, a 25% decrease compared to previous year.
Array BioPharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on September 14, 2018.